private

Why Canada's stock market transformation is taking so long

It’s been more than four years now since the giddily titled book Go Canada: The Coming Boom in the Toronto Stock Market and How to Profit From It hit store shelves, advising its hopeful readers that within a decade the Toronto Stock Exchange would more than double in value to 30,000 points. Spoiler alert: not gonna happen. Since the release […]

Lance Roberts, Things To Ponder: Shades Or Umbrella

Since the beginning of this year the markets have primarily treaded water. The primary support for the bulls has been continued acknowledgement by the Fed on an inability to remove accommodative policy by raising interest rates. (Which should make you question what happens the first time they do.) The bears have been feasting on weak economic data and deteriorating fundamentals. […]

5 Things To Ponder: Shades Or Umbrella

Submitted by Lance Roberts via STA Wealth Management,Since the beginning of this year the markets have primarily treaded water. The primary support for the bulls has been continued acknowledgement by the Fed on an inability to remove accommodative policy by raising interest rates. (Which should make you question what happens the first time they do.) The bears have been feasting […]

Fed Shift Is Major Stock Market Risk :: The Market Oracle :: Financial …

Fed Shift Is Major Stock Market RiskStock-Markets / Stock Markets 2015Jun 19, 2015 – 05:43 PM GMTBy: Zeal_LLCThe US stock markets were quick to rally after the Federal Reserve did nothing at its policy meeting this week. Traders love the endless dovishness gushing forth from this Yellen Fed. But their complacency is very misplaced. It was epic Fed easing that […]

SEC Says Fantasy Stock Trading Violates Security Laws; Charges …

SEC Says Fantasy Stock Trading Violates Securities Laws; Charges Others for Selling Illegal Security-Based Swapsby Steve Quinlivan | June 17, 2015The SEC issued an Investor Alert which says fantasy stock trading for small amounts of money can violate provisions of securities laws implemented by the Dodd-Frank Act.  I bet the Congressional drafters of these provisions who were trying to prevent […]

Would You Rather Own The Unicorns, or Facebook?

Back in 2000 I was a biomedical engineering student at Virginia (who happens to be in the College baseball World Series, go Hoos!).  I was in love with genetics and all things biotech, but also spent plenty of time reading annual reports and buying and selling (often shorting) stocks.  One of the classes I enrolled in outside of engineering (if you are […]

Discover a New Way of Thinking About Society and the Stock Market …

Discover a New Way of Thinking About Society and the Stock MarketStock-Markets / Stock Markets 2015Jun 17, 2015 – 08:32 AM GMTBy: EWIEditor’s note: This video was excerpted from a new multimedia report, “The New Financial Theory that Could Make the Difference in Your Investing Success,” from Elliott Wave International, the world’s largest financial forecasting firm. Authored by Robert Prechter, […]

Best Investor Play in the Hottest Biotech Stock Market on Earth :: The …

Best Investor Play in the Hottest Biotech Stock Market on EarthCompanies / Tech StocksJun 17, 2015 – 08:01 AM GMTBy: Money_MorningMichael A. Robinson writes: Biotechnology is a big opportunity. And China is a big market.Combine the two and you have a big potential for investment profits.In today’s Strategic Tech Investor, I’m talking with Money Map Press Executive Editor William Patalon […]

Crescat Capital Quarterly Investor Letter Q2 2015

Download Letter (PDF)June 12, 2015Crescat Capital Quarterly Investor Letter Q2 2015Performance UpdateWe are pleased to report that the Crescat Global Macro Fund was recently named one of the top-ten performing global macro hedge funds by BarclayHedge for the three years ended 3/31/2015. As shown in the table below, all three Crescat strategies performed strongly in Q1 while the S&P 500 […]

Biotech Stock Roundup: FDA Panel Recommends Regeneron's …

An FDA advisory panel voted in favor of approving Regeneron (REGN – Analyst Report) and partner Sanofi’s PCSK9 inhibitor, Praluent. A few deals were also signed over the last few days by companies like Vertex (VRTX – Analyst Report), Celgene (CELG – Analyst Report) and Seattle Genetics (SGEN – Analyst Report).Recap of the Week’s Most Important Stories1. Regeneron and Sanofi […]